- Liver disease occurs in 3% of pregnancies and can be coincidental, preexisting conditions exacerbated by pregnancy, or specific to pregnancy.
- It is important to determine the etiology to guide management. Common causes include viral hepatitis, cholelithiasis, portal hypertension, hyperemesis gravidarum, Budd-Chiari syndrome, Wilson's disease, autoimmune hepatitis.
- Many conditions pose risks to both mother and baby such as complications, mortality, fetal loss, prematurity or transmission. Careful monitoring and treatment optimized for pregnancy is needed.
Dr Abdullah Ansari
MBBS, MD Medicine
Aligarh Muslim University
The physiological changes in the liver during pregnancy
The possibilities of liver diseases
LFT in pregnancy
Intercurrent and pre-existing liver disease: viral hepatitis, autoimmune hepatitis, gall stones
Pregnancy associated liver disease: Hyperemesis Gravidarum, Acute cholestasis of pregnancy, Acute fatty liver of pregnancy, HELLP syndrome
Dr Abdullah Ansari
MBBS, MD Medicine
Aligarh Muslim University
The physiological changes in the liver during pregnancy
The possibilities of liver diseases
LFT in pregnancy
Intercurrent and pre-existing liver disease: viral hepatitis, autoimmune hepatitis, gall stones
Pregnancy associated liver disease: Hyperemesis Gravidarum, Acute cholestasis of pregnancy, Acute fatty liver of pregnancy, HELLP syndrome
Struggling with intense fears that disrupt your life? At Renew Life Hypnosis, we offer specialized hypnosis to overcome fear. Phobias are exaggerated fears, often stemming from past traumas or learned behaviors. Hypnotherapy addresses these deep-seated fears by accessing the subconscious mind, helping you change your reactions to phobic triggers. Our expert therapists guide you into a state of deep relaxation, allowing you to transform your responses and reduce anxiety. Experience increased confidence and freedom from phobias with our personalized approach. Ready to live a fear-free life? Visit us at Renew Life Hypnosis..
R3 Stem Cells and Kidney Repair A New Horizon in Nephrology.pptxR3 Stem Cell
R3 Stem Cells and Kidney Repair: A New Horizon in Nephrology" explores groundbreaking advancements in the use of R3 stem cells for kidney disease treatment. This insightful piece delves into the potential of these cells to regenerate damaged kidney tissue, offering new hope for patients and reshaping the future of nephrology.
Medical Technology Tackles New Health Care Demand - Research Report - March 2...pchutichetpong
M Capital Group (“MCG”) predicts that with, against, despite, and even without the global pandemic, the medical technology (MedTech) industry shows signs of continuous healthy growth, driven by smaller, faster, and cheaper devices, growing demand for home-based applications, technological innovation, strategic acquisitions, investments, and SPAC listings. MCG predicts that this should reflects itself in annual growth of over 6%, well beyond 2028.
According to Chris Mouchabhani, Managing Partner at M Capital Group, “Despite all economic scenarios that one may consider, beyond overall economic shocks, medical technology should remain one of the most promising and robust sectors over the short to medium term and well beyond 2028.”
There is a movement towards home-based care for the elderly, next generation scanning and MRI devices, wearable technology, artificial intelligence incorporation, and online connectivity. Experts also see a focus on predictive, preventive, personalized, participatory, and precision medicine, with rising levels of integration of home care and technological innovation.
The average cost of treatment has been rising across the board, creating additional financial burdens to governments, healthcare providers and insurance companies. According to MCG, cost-per-inpatient-stay in the United States alone rose on average annually by over 13% between 2014 to 2021, leading MedTech to focus research efforts on optimized medical equipment at lower price points, whilst emphasizing portability and ease of use. Namely, 46% of the 1,008 medical technology companies in the 2021 MedTech Innovator (“MTI”) database are focusing on prevention, wellness, detection, or diagnosis, signaling a clear push for preventive care to also tackle costs.
In addition, there has also been a lasting impact on consumer and medical demand for home care, supported by the pandemic. Lockdowns, closure of care facilities, and healthcare systems subjected to capacity pressure, accelerated demand away from traditional inpatient care. Now, outpatient care solutions are driving industry production, with nearly 70% of recent diagnostics start-up companies producing products in areas such as ambulatory clinics, at-home care, and self-administered diagnostics.
2. Introduction
3% of pregnancy
Mild to severe
Coincidental A/c hepatobiliary disease
Preexisting Hepatobiliary disease
exacerbated by pregnancy
Hepatobiliary disease specific to pregnancy
Vital to make etiologic diagnosis
3. Physiologic changes
Decrease is serum albumin
Increase in S.alkaline Phosphatase
S. bil, AST/ALT, LDH, GGT, PT, remain normal
Palmar erythema, spider naevi
Liver span
Increased blood volume, decreased peripheral
resistance, increased cardiac output, increased
splanchenic circulation, increased IVC pressure
4.
5.
6. Viral Hepatitis
Most common cause of jaundice in
pregnancy
HEV, HSV – Mortality is increased
HAV –
Same course
Maternal fetal transmission
No fetal loss or developmental anomalies
No CI for breast feeding
7. Viral Hepatitis
Hepatitis B
A/c HBV Course not altered
C/c HBV
Risk of transmission
HBeAg positive- 90%
HBeAg Negative – 10-40%
Risk more if infection occurs in 3rd trimester
HBV Ig + Vaccination
Lamivudine
8. Viral Hepatitis
HCV
Does not interfere with normal pregnancy
Vertical transmission of HCV - 0-36%
HIV co infection, HCV RNA levels more than 1
million copies/ml, IV drug abuse
No contraindication for breast feeding
A/c infection less chance for transmission
Interferon and Ribavarin - CI
9. Viral Hepatitis
HEV
Females in child bearing age group
58% can develop fulminant hepatitis
Mortality 1st -1.5%, 2nd -8.5%, 3rd -21%
Increased risk of abortions
No CI for breast feeding
HDV
No vertical transmission reported
11. Cholelithiasis
6% of pregnancy
Decreased bile acid pool
Increased bile cholesterol
Impaired contraction of GB
Cholecystitis, Cholangitis and gall stone
pancreatitis
Gall stone pancreatitis has 15%MMR and 60%
fetal mortality
Laparoscopic cholecystectomy can safely be
done in 1st and2nd
ERCP
12. Portal Hypertension
Cirrhosis V/s NCPHT
Cirrhosis – pregnancy is rare
NCPHT – Liver function and fertility
Increased portal pressure - Maximum in
2nd trimester
Increased risk of variceal bleed in 2nd
trimester and 2nd stage of labor
18. Hyperemesis gravidarum
2% of pregnancies
Severe dehydration, electrolyte imbalance
Young age, obese, non smokers,
hyperthyroidism
50% have elevated transaminases
Mild hyperbilirubinemia
IVF, antiemetics
Good outcome
Low birth weight
19. Budd chiari syndrome
20%
2nd trimester to 3 months after pregnancy
Hypercoagulable state
Ascites
A/C v/s C/C
Anticoagulation
TIPS
Transplant
20. Wilsons disease
Decreased fertility
Treatment same as non pregnant
D Pencillamine- micrognathia, low set
ears, inguinal hernia and cutis laxa
Trientene and oral Zinc also safe
21. Autoimmune hepatitis
Course is augmented
Maternal mortality and morbidity increased
Fetal loss is 13-44%
Steroids / azathioprin
22. Liver Transplant and Pregnancy
High risk pregnancy
Conception delayed up to 6 months
Increased risk of preecclampsia
Well tolerated provided graft function and
renal function are normal
23.
24. Dengue and pregnancy
Can mimic HELLP/AFLP
Vertical transmission
Fever, thrombocytopenia, hepatomegaly,
circulatory failure
Severe thrombocytopenia can lead to PPH
25. Leptospirosis and pregnancy
Fetal wastage, premature delivery
Vertical transmission
No congenital infection
Mimic HELLP syndrome